Potential of targeting TROP2 in the treatment of pancreatic cancer

Potential of targeting TROP2 in the treatment of pancreatic cancer

Pancreatic cancer is a malignant tumor with high incidence, rapid progression and low survival rate. It is in urgent need of new targets for precise treatment or improvement of prognosis. In recent years, it has been found that trophoblast cell surface antigen 2 (TROP2) is highly expressed in a vari...

Full description

Bibliographic Details
Main Author:	LI Yujie, CHEN Hao
Format:	Article
Language:	English
Published:	Editorial Office of China Oncology 2022-03-01
Series:	Zhongguo aizheng zazhi
Subjects:	\|pancreatic cancer\|trophoblast cell surface antigen 2\|targeted therapy\|research progress
Online Access:	http://www.china-oncology.com/fileup/1007-3639/PDF/1648875978161-377748608.pdf

Similar Items

Decoding TROP2 in breast cancer: significance, clinical implications, and therapeutic advancements
by: Liqin Yao, et al.
Published: (2023-10-01)

A multicenter study on TROP2 as a potential targeted therapy for extramammary Paget disease in Japan
by: Takamichi Ito, et al.
Published: (2025-01-01)

Toxicarioside O Inhibits Cell Proliferation and Epithelial-Mesenchymal Transition by Downregulation of Trop2 in Lung Cancer Cells
by: Wu-Ping Zheng, et al.
Published: (2021-02-01)

Antibody-drug conjugates targeting TROP-2: Clinical development in metastatic breast cancer
by: Mythili Shastry, et al.
Published: (2022-12-01)

TROP2 is highly expressed in triple-negative breast cancer CTCs and is a potential marker for epithelial mesenchymal CTCs
by: Qingyu Liao, et al.
Published: (2024-03-01)

Advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2021
by: ZHU Xinzhe, LI Hao, XU Huaxiang, LUO Guopei, YU Xianjun
Published: (2022-01-01)

Candidate Biomarkers for Targeting in Type 1 Diabetes; A Bioinformatic Analysis of Pancreatic Cell Surface Antigens
by: Hamed Dabiri, et al.
Published: (2024-01-01)

Trop-2 in Upper Tract Urothelial Carcinoma
by: Eisuke Tomiyama, et al.
Published: (2022-05-01)

In advanced pancreatic cancer: The value and significance of interventional therapy
by: Chao Hu, et al.
Published: (2020-09-01)

Pancreatic stellate cells in pancreatic cancer: as potential targets for future therapy
by: Zhengfeng Wang, et al.
Published: (2023-06-01)

Lipid metabolism in pancreatic cancer: emerging roles and potential targets
by: Xinpeng Yin, et al.
Published: (2022-12-01)

Rationale for MYC imaging and targeting in pancreatic cancer
by: Günter Schneider, et al.
Published: (2021-10-01)

<it>In vivo</it> gene transfer targeting in pancreatic adenocarcinoma with cell surface antigens
by: Lafitte Marie, et al.
Published: (2012-10-01)

Trophoblast Cell Surface Antigen 2 (Trop2) Is Expressed in Cases of EBV-Positive Diffuse Large B-Cell Lymphoma Emerging from Angioimmunoblastic T-Cell Lymphoma
by: Susanne Ghandili, et al.
Published: (2024-05-01)

Phase 1a study of ESG401, a Trop2 antibody-drug conjugate, in patients with locally advanced/metastatic solid tumors
by: Jiani Wang, et al.
Published: (2024-09-01)

Research progress of MDSCs-targeted immunotherapy for pancreatic cancer
by: QIN Yahan, et al.
Published: (2023-10-01)

Trop2-targeted therapy in breast cancer
by: Yixuan Hu, et al.
Published: (2024-08-01)

Target Nanoparticles against Pancreatic Cancer: Fewer Side Effects in Therapy
by: Jorge A. Roacho-Pérez, et al.
Published: (2021-11-01)

The complex role of macrophages in pancreatic cancer tumor microenvironment: a review on cancer progression and potential therapeutic targets
by: Parsa Lorestani, et al.
Published: (2024-08-01)

Dissecting FGF Signalling to Target Cellular Crosstalk in Pancreatic Cancer
by: Edward P. Carter, et al.
Published: (2021-04-01)

Consensus, debate, and prospective on pancreatic cancer treatments
by: Junke Wang, et al.
Published: (2024-10-01)

Recent Advances in the Potential Use of Circular RNA for the Diagnosis and Treatment of Pancreatic Cancer
by: Sun X, et al.
Published: (2021-05-01)

Targeting dendritic cells in pancreatic ductal adenocarcinoma
by: Anton Deicher, et al.
Published: (2018-06-01)

Photoimmunotherapy targeting biliary‐pancreatic cancer with humanized anti‐TROP2 antibody
by: Takashi Nishimura, et al.
Published: (2019-12-01)

Advanced pancreatic cancer: the standard of care and new opportunities
by: Amrallah A. Mohammad
Published: (2018-09-01)

Metastatic Pancreatic Cancer: Where Are We?
by: Abraham Hernández-Blanquisett, et al.
Published: (2024-01-01)

Phage-based peptides for pancreatic cancer diagnosis and treatment: alternative approach
by: Yang Li, et al.
Published: (2023-08-01)

Chimeric Antigen Receptor T Cell Therapy for Pancreatic Cancer: A Review of Current Evidence
by: Agata Czaplicka, et al.
Published: (2024-01-01)

Association of the Microbiota and Pancreatic Cancer: Opportunities and Limitations
by: Zhou Chen, et al.
Published: (2022-03-01)

The Art of War: Ferroptosis and Pancreatic Cancer
by: Jiao Liu, et al.
Published: (2021-12-01)

NMDA receptors are important regulators of pancreatic cancer and are potential targets for treatment
by: North WG, et al.
Published: (2017-07-01)

Genetic Redirection of T Cells for the Treatment of Pancreatic Cancer
by: Aesha I. Ali, et al.
Published: (2019-02-01)

Integrating plasma protein-centric multi-omics to identify potential therapeutic targets for pancreatic cancer
by: Siyu Zhou, et al.
Published: (2024-06-01)

Research Progress and Perspectives of Antibody-drug Conjugates Targeting Trophoblast Cell Surface Antigen-2 in Advanced Non-small Cell Lung Cancer
by: Jingyan XU, et al.
Published: (2024-10-01)

Recent Advances in Pancreatic Cancer: Novel Prognostic Biomarkers and Targeted Therapy—A Review of the Literature
by: Konstantin Schlick, et al.
Published: (2021-10-01)

Bone marrow mesenchymal stem cells-derived exosomes for penetrating and targeted chemotherapy of pancreatic cancer
by: Yu Zhou, et al.
Published: (2020-08-01)

The Role of Feedback Loops in Targeted Therapy for Pancreatic Cancer
by: Weigang Gu, et al.
Published: (2022-05-01)

Advances in pancreatic cancer immunotherapy for targeting programmed death-ligand 1
by: Haitao Jiang, et al.
Published: (2023-06-01)

Diagnostic Value of CK19, HBME-1 and TROP2 Biomarkers in Identification of Different Types of Thyroid Follicular Neoplasms
by: Masoud Mohebbi, et al.
Published: (2021-02-01)

Apoptosis: Targets in Pancreatic Cancer
by: Kalthoff Holger, et al.
Published: (2003-01-01)